European youth care sites serve different populations of adolescents with cannabis use disorder. Baseline and referral data from the INCANT trial

O. PHAN ; C. E. HENDERSON ; T. ANGELIDIS ; P. WEIL ; M. VAN TOORN ; R. RIGTER ; C. SORIA ; H. RIGTER | 2011
Dans BMC Psychiatry (Vol.11, n°110, 12 July 2011) Article : Périodique

Background: MDFT (Multidimensional Family Therapy) is a family based outpatient treatment programme for adolescent problem behaviour. MDFT has been found effective in the USA in adolescent samples differing in severity and treatment delivery set[...]

Plus d'info

Ajouter à la sélection

Lien externe

Implementation fidelity of Multidimensional Family Therapy in an international trial

C. ROWE ; H. RIGTER ; C. HENDERSON ; A. GANTNER ; K. MOS ; P. NIELSEN ; O. PHAN | 2013
Dans Journal of Substance Abuse Treatment (Vol.44, n°4, April 2013) Article : Périodique

Implementation fidelity, a critical aspect of clinical trials research that establishes adequate delivery of the treatment as prescribed in treatment manuals and protocols, is also essential to the successful implementation of effective programs[...]

Plus d'info

Ajouter à la sélection

INCANT: a transnational randomized trial of Multidimensional Family Therapy versus treatment as usual for adolescents with cannabis use disorder

H. RIGTER ; I. PELC ; P. TOSSMANN ; O. PHAN ; E. GRICHTING ; V. HENDRIKS ; C. ROWE | 2010
Dans BMC Psychiatry (Vol.10, n°28, 9 April 2010) Article : Périodique

BACKGROUND: In 2003, the governments of Belgium, France, Germany, the Netherlands and Switzerland agreed that there was a need in Europe for a treatment programme for adolescents with cannabis use disorders and other behavioural problems. Based [...]

Plus d'info

Ajouter à la sélection

Lien externe

Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: A randomised controlled trial in Western European outpatient settings

H. RIGTER ; C. E. HENDERSON ; I. PELC ; P. TOSSMANN ; O. PHAN ; V. HENDRIKS ; M. SCHAUB | 2013
Dans Drug and Alcohol Dependence (Vol.130, n°1-3, June 2013) Article : Périodique

Background: Noticing a lack of evidence-based programmes for treating adolescents heavily using cannabis in Europe, government representatives from Belgium, France, Germany, The Netherlands, and Switzerland decided to have U.S.-developed multidi[...]

Plus d'info

Ajouter à la sélection

N-methyl-1-1(1,3-benzodioxol-5-yl)-2-butanamine (MBDB) : its properties and possible risks

J. M. VAN AERTS ; M. MALLARET ; H. RIGTER | 2000
Périodique

FRANÇAIS : La MBDB, homologue alpha-éthylé de la MDMA, a un métabolisme et une élimination similaires à ceux de la MDMA. Chez le rat, son effet neuropharmacologique aigu majeur est une augmentation de la libération de la sérotonine et une inhib[...]

Plus d'info

Ajouter à la sélection

Treatment of problematic use of drugs. State of the art for evidence based treatments and other interventions, 2004

H. RIGTER ; A. VAN GAGELDONK ; T. KETELAARS ; M. VAN LAAR | 2004
Rapport

Addiction is best seen as a chronic, though not incurable disorder that is not just the product of the characteristics of the drug but also of biological (including hereditary), personal and social influences. This view is also called the biopsy[...]

Plus d'info

Ajouter à la sélection

Lien externe

What drug policies cost. Drug policy spending in the Netherlands in 2003

H. RIGTER | 2006
Périodique

ENGLISH : Aim: To estimate the public spending on drug policy in the Netherlands. Methods: Calculation and extrapolation of expenditures from 2003 budgets of all Ministries of the national government, annual reports from other governments and [...]

Plus d'info

Ajouter à la sélection